Results from a randomized trial indicate Saphris was effective and well-tolerated among adolescents with bipolar I disorder and manic or mixed episodes. “Several atypical antipsychotics (risperidone, ...

Rapport Therapeutics, Inc. (($RAPP)) announced an update on their ongoing clinical study. Study Overview: Rapport Therapeutics, Inc. is conducting ...

Bristol-Myers Squibb Company (($BMY)) announced an update on their ongoing clinical study. Bristol-Myers Squibb Company (BMY) ...

KIRKLAND, QC, Jan. 22 /CNW/ - Pfizer Canada Inc. announced today that Health Canada has approved ZELDOX (ziprasidone hydrochloride), for use in the treatment of acute manic or mixed episodes ...

March 3, 2009 — The presence of manic symptoms coexisting with depression may predict treatment-emergent mania caused by antidepressant therapy, a small study suggests. Three manic symptoms in ...

The approval of medicines called second-generation antipsychotics has allowed bipolar I and other associated conditions to be treated. A person with bipolar I disorder can go through various mood ...

Schizophrenia and bipolar I disorder are two conditions that have many differences between them. A class of medicines called antipsychotics can be used to treat both conditions but may cause unwanted ...

Bipolar disorder exists on a spectrum rather than as a single, uniform condition. This fundamental characteristic explains why two people with the same diagnosis can experience dramatically different ...

Yesterday, I couldn’t stand being inside my skin. It felt like a prison, this body of mine that didn’t know what it wanted or why it was here. I squirmed through the day, fussing and eating and eating ...

Bipolar disorders present a high rate of misdiagnosis issues (e.g., Rakofsky et al., 2015; Shen et al., 2018; McIntyre et al., 2022). This has a lot to do with poor differential diagnosis practice and ...